loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 88448 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DEXAMETHASONE SODIUM PHOSPHATE (1)

filter

01 ABRAXIS PHARM (1)

filter

01 INJECTABLE;INJECTION (1)

filter

01 EQ 4MG PHOSPHATE/ML (1)

filter

01 USA (1)

Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
INJECTABLE;INJECTION
EQ 4MG PHOSPHATE/ML
DEXAMETHASONE
USA
88448
1984-01-25
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 88448

Looking for CTD TGA MCC DOSSIER APPLICATION 88448 1

19

ABRAXIS PHARM, based in U.S.A, is a pharmaceutical company.

One of their notable products is DEXAMETHASONE SODIUM PHOSPHATE, with a corresponding application number 88448 and regulatory information .

proudly manufactured in the

approval since 1984-01-25

ABRAXIS PHARM's DEXAMETHASONE INJECTABLE;INJECTION, medication with EQ 4MG PHOSPHATE/ML of DEXAMETHASONE SODIUM PHOSPHATE.

Post Enquiry
POST ENQUIRY